Table 1 Demographics of 284 patients with metastatic angiosarcomas identified from SEER database between 2010 and 2016
Category | N (%) |
|---|---|
Age at diagnosis(years) | |
≤ 60 | 128(45.1%) |
> 60 | 156(54.9%) |
mean | 60.5 Years |
median | 63 Years |
Gender | |
Female | 102(35.9%) |
Male | 182(64.1%) |
Race | |
White | 228(80.3%) |
Black | 25(8.8%) |
Other | 31(10.9%) |
Year of diagnosis | |
2010–2012 | 111(39.1%) |
2013–2014 | 86(30.3%) |
2015–2016 | 87(30.6%) |
Metastatic sites at diagnosis | |
Bone | |
Yes | 121(42.6%) |
No | 163(57.4%) |
Brain | |
Yes | 26(9.2%) |
No | 258(90.8%) |
Liver | |
Yes | 86(30.3%) |
No | 198(69.7) |
Lung | |
Yes | 171(60.2%) |
No | 113(39.8%) |
Number of metastatic sites | |
1 | 188(66.2%) |
≥ 2 | 96(33.8%) |
Grade | |
I + II | 6(2.1%) |
III | 52(18.3%) |
IV | 50(17.6%) |
Unknown | 176(62.0%) |
Size(cm) | |
≤ 10 | 110(38.7%) |
> 10 | 44(15.5%) |
Unknown | 130(45.8%) |
Treatment | |
Chemotherapy | |
Yes | 145(51.1%) |
No | 139(48.9%) |
RT | |
Yes | 66(23.2%) |
No | 218(76.8%) |
ST | |
Yes | 83(29.2%) |
No | 201(70.8%) |
Dead | |
Yes | 253(89.1%) |
No | 31(10.9%) |
1-year OS rate | 20.8% |
3-year OS rate | 3.8% |
1-year CSS rate | 22.0% |
3-year CSS rate | 5.2% |